Policy to Assist Iteratively Local Segmentation: Optimising Modality and Location Selection for Prostate Cancer Localisation

Radiologists often mix medical image reading strategies, including inspection of individual modalities and local image regions, using information at different locations from different images independently as well as concurrently. In this paper, we propose a recommend system to assist machine learning-based segmentation models, by suggesting appropriate image portions along with the best modality, such that prostate cancer segmentation performance can be maximised. Our approach trains a policy network that assists tumor localisation, by recommending both the optimal imaging modality and the specific sections of interest for review. During training, a pre-trained segmentation network mimics radiologist inspection on individual or variable combinations of these imaging modalities and their sections - selected by the policy network. Taking the locally segmented regions as an input for the next step, this dynamic decision making process iterates until all cancers are best localised. We validate our method using a data set of 1325 labelled multiparametric MRI images from prostate cancer patients, demonstrating its potential to improve annotation efficiency and segmentation accuracy, especially when challenging pathology is present. Experimental results show that our approach can surpass standard segmentation networks. Perhaps more interestingly, our trained agent independently developed its own optimal strategy, which may or may not be consistent with current radiologist guidelines such as PI-RADS. This observation also suggests a promising interactive application, in which the proposed policy networks assist human radiologists.

AI-assisted prostate cancer detection and localisation on biparametric MR by classifying radiologist-positives

Prostate cancer diagnosis through MR imaging have currently relied on radiologists' interpretation, whilst modern AI-based methods have been developed to detect clinically significant cancers independent of radiologists. In this study, we propose to develop deep learning models that improve the overall cancer diagnostic accuracy, by classifying radiologist-identified patients or lesions (i.e. radiologist-positives), as opposed to the existing models that are trained to discriminate over all patients. We develop a single voxel-level classification model, with a simple percentage threshold to determine positive cases, at levels of lesions, Barzell-zones and patients. Based on the presented experiments from two clinical data sets, consisting of histopathology-labelled MR images from more than 800 and 500 patients in the respective UCLA and UCL PROMIS studies, we show that the proposed strategy can improve the diagnostic accuracy, by augmenting the radiologist reading of the MR imaging. Among varying definition of clinical significance, the proposed strategy, for example, achieved a specificity of 44.1% (with AI assistance) from 36.3% (by radiologists alone), at a controlled sensitivity of 80.0% on the publicly available UCLA data set. This provides measurable clinical values in a range of applications such as reducing unnecessary biopsies, lowering cost in cancer screening and quantifying risk in therapies.